Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02638285Phase 4Completed
Phase 4, randomised, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pregnancy Rate at 2 weeks. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02638285.